Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
98,489,676
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
32,607,853
-
Shares change
-
+8,039,607
-
Total reported value, excl. options
-
$1,103,814,951
-
Value change
-
+$273,075,064
-
Number of buys
-
62
-
Number of sells
-
-10
-
Price
-
$33.85
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q4 2020
79 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q4 2020.
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) has 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,607,853 shares
of 98,489,676 outstanding shares and own 33% of the company stock.
Largest 10 shareholders include FMR LLC (5,452,347 shares), Column Group LLC (4,768,181 shares), EcoR1 Capital, LLC (3,092,218 shares), ORBIMED ADVISORS LLC (2,921,967 shares), BlackRock Inc. (1,878,908 shares), Euclidean Capital LLC (1,400,435 shares), VICTORY CAPITAL MANAGEMENT INC (1,100,293 shares), ArrowMark Colorado Holdings LLC (1,052,879 shares), Invus Financial Advisors, LLC (1,007,575 shares), and ALKEON CAPITAL MANAGEMENT LLC (898,061 shares).
This table shows the top 76 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.